WASHINGTON (Reuters) - U.S. regulators gave the nod to an imaging test from Eli Lilly and Co. that can for the first time help doctors detect brain plaque tied to Alzheimer's disease, the company said.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/KpAJMZNJOWI/us-fda-lilly-amyvid-idUSBRE8360C220120407
phlebotomist training california phlebotomy school school phlebotomy
No comments:
Post a Comment